This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
User:Kerry Frattarola/Sandbox 1
From Proteopedia
(Difference between revisions)
| Line 4: | Line 4: | ||
==Structure== | ==Structure== | ||
| + | Indinavir is an antiviral compound that acts as a protease inhibiter. Figure 2 below depicts Indinavir’s structure. The drug has a molecular weight of 711.875 g/mol and is very soluble in water and ethanol. Indinavir works by specifically binding to the HIV-1 protease active site by mimicking a target substrate protein and essentially becoming “stuck” in the enzyme active site, disabling the enzyme. The Arginine in the protease interacts with Indinavir’s pyridine to hold it in place. The hydroxyl groups off the cyclopentanes, ketone and amide interact with the Asp25 of HIV-1 protease to perform catabolism (1). | ||
== Function == | == Function == | ||
Revision as of 03:29, 16 November 2016
Human Immunodeficiency Virus protease inhibitor
| |||||||||||
